BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 25, 2012
View Archived Issues
Itraconazole shows promise as an antiangiogenic and antitumor agent
Read More
New amatoxin conjugates patented by Heidelberg Pharma
Read More
Novel LRRK2 inhibitors prepared at Merck & Co.
Read More
Orchid Chemicals & Pharmaceuticals discloses new HDAC6 inhibitors
Read More
Japanese researchers synthesize new vitamin D receptor modulators
Read More
Novel anticancer agents presented by Kitasato Institute
Read More
New OGA inhibitors patented by Summit Corporation
Read More
Companies to develop self-injectable treprostinil
Read More
NX-1207 prostate cancer trial receives positive interim safety review
Read More
MBC Pharma and Maxwell Biotech enter joint venture in metastatic bone disease
Read More
FDA approves denosumab in new indication
Read More
MorphoSys reports phase Ib/IIa MOR-103 study results
Read More
Aradigm's inhaled liposomal ciprofloxacin shows promise in mouse models
Read More
First-in-human study of Opal-HIV-Gag(c) terminated
Read More
Eliglustat efficacy maintained for 4 years in patients with Gaucher's disease
Read More
Astex Pharmaceuticals discontinues amuvatinib development
Read More
Navidea Biopharmaceuticals receives NIH grant to develop RIGS agent
Read More
EMA committee recommends approval of new apixaban indication
Read More
ViroPharma and Halozyme provide update on development of Cinryze/rHuPH20
Read More
Sequestosome-1 identified as a biomarker of melanoma
Read More
CHMP recommends Constella in IBS-C
Read More
NewLink and Dendreon to collaborate on phase II study of combination treatment for prostate cancer
Read More
VIVUS anticipates CHMP opinion on Qsiva MAA
Read More
CHMP recommends expanded approval of Trajenta tablets
Read More